These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 31766991

  • 21. Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage.
    Muller P, Coates PJ, Nenutil R, Trcka F, Hrstka R, Chovanec J, Brychtova V, Vojtesek B.
    J Ovarian Res; 2019 Mar 27; 12(1):30. PubMed ID: 30917858
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
    Zhu Q, Wu X, Wu Y, Wang X.
    Oncol Rep; 2016 Dec 27; 36(6):3472-3478. PubMed ID: 27748885
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.
    Sopo M, Anttila M, Hämäläinen K, Kivelä A, Ylä-Herttuala S, Kosma VM, Keski-Nisula L, Sallinen H.
    BMC Cancer; 2019 Jun 14; 19(1):584. PubMed ID: 31200683
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Early inflammatory response in epithelial ovarian tumor cyst fluids.
    Kristjánsdóttir B, Partheen K, Fung ET, Yip C, Levan K, Sundfeldt K.
    Cancer Med; 2014 Oct 14; 3(5):1302-12. PubMed ID: 24947406
    [Abstract] [Full Text] [Related]

  • 30. Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
    Carbotti G, Orengo AM, Mezzanzanica D, Bagnoli M, Brizzolara A, Emionite L, Puppo A, Centurioni MG, Bruzzone M, Marroni P, Rossello A, Canevari S, Ferrini S, Fabbi M.
    Int J Cancer; 2013 Jun 01; 132(11):2597-605. PubMed ID: 23169448
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.
    Huo J, Hu J, Liu G, Cui Y, Ju Y.
    Arch Gynecol Obstet; 2017 Feb 01; 295(2):459-465. PubMed ID: 27975129
    [Abstract] [Full Text] [Related]

  • 33. Expression of orphan GPR56 correlates with tumor progression in human epithelial ovarian cancer.
    Liu Z, Huang Z, Yang W, Li Z, Xing S, Li H, Hu B, Li P.
    Neoplasma; 2017 Feb 01; 64(1):32-39. PubMed ID: 27881002
    [Abstract] [Full Text] [Related]

  • 34. CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma.
    Shen H, Cai M, Zhao S, Wang H, Li M, Yao S, Jiang N.
    Med Oncol; 2014 Aug 01; 31(8):117. PubMed ID: 25048722
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.